Boehringer's Hernexeos is now FDA-approved for patients with HER2-positive NSCLC, bringing it into direct competition with ADC Enhertu.

Biostar Stem Cell Technology Research Institute has received Japan's MHLW approval for its angel stem cell therapy for ASD.

Denny Bros will be attending London Packaging Week 2025 on the 15th and 16th of October, and their booth number is C84.

Arvinas, in collaboration with Pfizer, has announced vepdegestrant NDA acceptance by the FDA for breast cancer treatment.

Linked data could unlock essential hidden insights across healthcare – but linking has to be executed correctly to avoid ...

The FDA’s new PreCheck programme is aimed at facilitating the introduction of new US drug manufacturing facilities.

H1 sales growth for Novo Nordisk’s segment that includes Ozempic and Wegovy was down from the same period in 2024.

Primary packaging is never an afterthought in the world of injectable drugs, where systems such as vials, syringes, and ...

Gilead's PrEP Yeztugo is set to become the pharma's star asset, with GlobalData forecasting of just under $5bn in 2031.

Spanning topics across R&D, clinical trials, and commercial launch, our podcast series continues as two clinical supplies ...

The upcoming EpiPen patent expiration on 11 September 2025 sets the stage for a pivotal shift in the epinephrine delivery market.